About the journal
Biomarker Insights is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 1177-2719
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,650 USD
- Articles in DOAJ
- 685
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.sagepub.com/home/bmi
Index listings
- DOAJ · 2007-05-31
- PUBMED · 2007-02-07
- Indexing
- DOAJ · PUBMED
- APC
- 2,650 USD
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
685
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
467
Last recorded publication year
2026
h-index
51
i10-index
288
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2024-04-04
- Added to DOAJ
- 2007-05-31
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 61%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101288638
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Advanced Proteomics Techniques and Applications
- Advanced Proteomics Techniques and Applications
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Sepsis Diagnosis and Treatment
- Sepsis Diagnosis and Treatment
- Molecular Biology Techniques and Applications
- Molecular Biology Techniques and Applications
Show all subjects (50)
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Protease and Inhibitor Mechanisms
- Protease and Inhibitor Mechanisms
- Gene expression and cancer classification
- Gene expression and cancer classification
- Metabolomics and Mass Spectrometry Studies
- S100 Proteins and Annexins
- S100 Proteins and Annexins
- Metabolomics and Mass Spectrometry Studies
- Ferroptosis and cancer prognosis
- Chronic Kidney Disease and Diabetes
- COVID-19 Clinical Research Studies
- Chronic Kidney Disease and Diabetes
- COVID-19 Clinical Research Studies
- Ferroptosis and cancer prognosis
- Bioinformatics and Genomic Networks
- Bioinformatics and Genomic Networks
- Liver Disease Diagnosis and Treatment
- Cancer Cells and Metastasis
- RNA modifications and cancer
- RNA modifications and cancer
- Pluripotent Stem Cells Research
- Liver Disease Diagnosis and Treatment
- Cancer Cells and Metastasis
- Extracellular vesicles in disease
- Pluripotent Stem Cells Research
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Extracellular vesicles in disease
- Inflammatory Biomarkers in Disease Prognosis
- Cancer-related molecular mechanisms research
- Inflammatory Biomarkers in Disease Prognosis
- Cancer-related molecular mechanisms research
- Autism Spectrum Disorder Research
- Epigenetics and DNA Methylation
- Autism Spectrum Disorder Research
- Rheumatoid Arthritis Research and Therapies
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- Rheumatoid Arthritis Research and Therapies
- Epigenetics and DNA Methylation
Keywords (DOAJ)
- biomarker
- genes
- markers
- protein
- pathway
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ